Trial Profile
Stepwise Medical Treatment of Cushing's Disease: a prospective, open label, multi-center trial with SOM230 mono- and combination therapy with dopamine agonists and ketoconazole for treatment of Cushing's disease
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 14 May 2009
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary) ; Cabergoline; Ketoconazole
- Indications Pituitary ACTH hypersecretion
- Focus Therapeutic Use
- 14 May 2009 New trial record